Updated Sep 1, 2026
/Memecoin buys on Robinhood Wallet and Fomo coded as "digital media," sidestepping card-network crypto rules/Caring Brands (CABR) Closes $4.6 Million Initial Series B Preferred Stock Private Placement/Sanmar Group takes majority stake in AltEons Energy to back 1.5GW India pipeline/MercadoLibre stock sits 26% below its 52-week high after three straight quarters of profit declines/10-year Treasury yield climbs to highest since January 2025 on oil and Middle East risk/Primis Financial director Allen Jones resigns, board falls to ten/Memecoin buys on Robinhood Wallet and Fomo coded as "digital media," sidestepping card-network crypto rules/Caring Brands (CABR) Closes $4.6 Million Initial Series B Preferred Stock Private Placement/Sanmar Group takes majority stake in AltEons Energy to back 1.5GW India pipeline/MercadoLibre stock sits 26% below its 52-week high after three straight quarters of profit declines/10-year Treasury yield climbs to highest since January 2025 on oil and Middle East risk/Primis Financial director Allen Jones resigns, board falls to ten

Caring Brands (CABR) Closes $4.6 Million Initial Series B Preferred Stock Private Placement

FORT PIERCE, Sept. 1. Caring Brands, Inc. recorded $4,600,000 in aggregate gross proceeds at the initial closing of a Series B Convertible Preferred Stock private placement, the company disclosed in an 8-K filed with the Securities and Exchange Commission on September 1, 2026. The Nasdaq-listed company trades under the ticker CABR.

By Corinne Ashford2 min readCABR
Share

Key takeaways

  • Caring Brands, Inc. (Nasdaq: CABR) closed the initial tranche of its Series B Convertible Preferred Stock private placement with $4,600,000 in aggregate gross proceeds, disclosed in an 8-K filed September 1, 2026.
  • At the initial closing the company issued 4,600 shares of Series B Convertible Preferred Stock at $1,000 per share, plus Series A Warrants (exercise price $0.825) and Series B Warrants (exercise price $0.95) each for up to 4,600,000 common shares.
  • The 4,600 preferred shares are initially convertible into 6,571,428 common shares at a $0.70 conversion price, subject to adjustment and to exchange cap and beneficial ownership limitations.
  • An additional $4,400,000 in subscription documents had been executed as of September 1, 2026, with that closing expected on or before September 4, 2026, subject to closing conditions.
  • Caring Brands also filed an Amended and Restated Certificate of Designation with the Nevada Secretary of State that deleted the 'Redemption Upon Triggering Event' section, eliminating that redemption right for Series A preferred holders.

FORT PIERCE, Sept. 1. Caring Brands, Inc. recorded $4,600,000 in aggregate gross proceeds at the initial closing of a Series B Convertible Preferred Stock private placement, the company disclosed in an 8-K filed with the Securities and Exchange Commission on September 1, 2026. The Nasdaq-listed company trades under the ticker CABR.

Under a Securities Purchase Agreement dated August 21, 2026, the company issued 4,600 shares of Series B Convertible Preferred Stock at $1,000 per share to accredited investors. Two warrant series accompanied the preferred stock: Series A Warrants to purchase up to 4,600,000 shares of common stock at an exercise price of $0.825 per share, and Series B Warrants to purchase up to 4,600,000 shares of common stock at $0.95 per share.

The 4,600 preferred shares are initially convertible into 6,571,428 shares of common stock at a conversion price of $0.70 per share, subject to adjustment and to exchange cap and beneficial ownership limitations set out in the company's prior 8-K filed August 25, 2026. Caring Brands said it intends to use net proceeds for working capital and general corporate purposes, subject to restrictions in the Purchase Agreement.

Additional closings remain pending. As of September 1, an additional $4,400,000 in subscription documents had been executed, the release shows, with the company waiting for the funds to clear. Upon receipt, Caring Brands expects to issue 4,400 additional shares of Series B Preferred Stock along with Series A and Series B Warrants to purchase up to 4,400,000 shares of common stock each. The company said it expects that closing to occur on or before September 4, 2026, subject to applicable closing conditions, and cautioned that no assurance can be given that any such closing will be completed, in whole or in part.

The offering is structured around up to 11,000 total shares of Series B Preferred Stock at $1,000 per share. All securities were sold in reliance on the exemption provided by Section 4(a)(2) of the Securities Act of 1933 and Rule 506(b) of Regulation D. The company filed no general solicitation was used, and all investors were parties to the Purchase Agreement as of August 21, 2026.

Separately, Caring Brands filed an Amended and Restated Certificate of Designation of Preferences, Rights and Limitations of Series A Convertible Preferred Stock with the Nevada Secretary of State. The amendment deleted the section entitled "Redemption Upon Triggering Event" in its entirety, eliminating that redemption right for holders of the company's Series A preferred stock.

Related reading

Frequently asked

How much did Caring Brands raise at the initial closing?

The company recorded $4,600,000 in aggregate gross proceeds by issuing 4,600 shares of Series B Convertible Preferred Stock at $1,000 per share.

What is the total size of the Series B offering?

The offering is structured around up to 11,000 total shares of Series B Preferred Stock at $1,000 per share.

What will the company do with the proceeds?

Caring Brands said it intends to use net proceeds for working capital and general corporate purposes, subject to restrictions in the Purchase Agreement.

When is the next closing expected?

An additional $4,400,000 in subscriptions had been executed, and the company expects that closing to occur on or before September 4, 2026, subject to applicable closing conditions, though no assurance was given.

Under what exemption were the securities sold?

All securities were sold in reliance on the exemption under Section 4(a)(2) of the Securities Act of 1933 and Rule 506(b) of Regulation D, with no general solicitation used.